Form 4 for TELO Telomir Pharmaceuticals, Inc.

Accepted 2024-02-15 00:00:00 ET · period of report 2024-02-13 · accession 0000897069-24-000395 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
MI	2024-02-15	2024-02-13	TELO	McNulty Brian Patrick	10%	P - Purchase	$7.00	+138.0K	1.90M	+8%	+$966.0K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2024-02-13	P	A	49,000	$7.00	5,455,431	I By Trust	—	—	(F1) These securities are owned directly by the Bay Shore Trust (the "Trust"), a 10% owner of the Issuer, and indirectly by Brian McNulty ("Mr. McNulty") as trustee of the Trust. Mr. McNulty disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
2	Common	Common Stock	2024-02-13	P	A	40,000	$7.00	1,365,646	I See Footnote	—	—	(F2) These securities are owned directly by the MIRALOGX, LLC, of which the Trust holds all of the membership interests, and indirectly by Mr. McNulty as trustee of the Trust. Mr. McNulty disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
3	Common	Common Stock	2024-02-13	P	A	49,000	$7.00	1,902,659	I By Trust	—	—	(F3) These securities are owned directly by a trust for which Mr. McNulty serves as trustee. Mr. McNulty disclaims beneficial ownership of the reported securities because he is deemed to hold these securities only because of his role as Trustee and does not have any pecuniary interest in such securities.